Back
Day Range
$33.65
$36.18
52-Week Range
$7.26
$45.00
Volume
257,421
50D / 200D Avg
$38.16
/
$30.86
Prev Close
$36.43
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.8 | 0.3 |
| P/B | 5.1 | 2.9 |
| ROE % | -105.2 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$46.25
+33.1%
Low: $24.00
High: $58.00
Forward EPS
-$2.33
Est. Revenue
0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$2.51
-$2.51 – -$2.51
|
74 M | 5 |
| FY2029 |
-$2.78
-$2.78 – -$2.78
|
33 M | 2 |
| FY2028 |
-$3.08
-$4.05 – -$1.71
|
4.3 M | 7 |
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -66.67M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-105.18%
ROIC-21.15%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.03
Current Ratio20.61
Interest Coverage0.00
Valuation
P/E Ratio
-20.78
P/B Ratio5.10
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -75.27M |
| ROE | -105.18% | ROA | -23.09% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -66.67M |
| ROIC | -21.15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 20.61 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.78 | P/B Ratio | 5.10 |
| P/S Ratio | N/A | PEG Ratio | -0.64 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.56B | Enterprise Value | 1.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -75.27M | -61.69M | -47.26M | -40.24M |
| EPS (Diluted) | -1.88 | -1.40 | -1.07 | -0.91 |
| Gross Profit | -647,000.0 | -668,000.0 | 0.0 | 0.0 |
| Operating Income | -88.98M | -70.56M | -50.33M | -41.37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 325.95M | 185.75M | 51.95M | 87.37M |
| Total Liabilities | 19.12M | 349.47M | 166.83M | 157.29M |
| Shareholders' Equity | 306.83M | -163.71M | -114.88M | -69.92M |
| Total Debt | 8.68M | 9.75M | 10.48M | 0.0 |
| Cash & Equivalents | 58.45M | 37.79M | 38.52M | 54.84M |
| Current Assets | 241.42M | 150.99M | 39.21M | 83.83M |
| Current Liabilities | 11.71M | 10.42M | 8.04M | 8.25M |